Tolerability and pharmacokinetics of fixed doses of buspirone administered transdermally to healthy subjects.

被引：0
|
作者：
Fulmor, IE
Szylleyko, OJ
Kollia, GD
Ford, NF
Salazar, DE
机构：
[1] Bristol Myers Squibb, Princeton, NJ USA
[2] IMTCI, Lenexa, KS USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 1999年 / 65卷 / 02期
关键词：
D O I：
10.1016/S0009-9236(99)80201-X
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PII83
引用
收藏
页码：167 / 167
页数：1
相关论文
共 50 条
  • [41] Effect of Multiple Doses of Omeprazole on the Pharmacokinetics, Safety, and Tolerability of Roxadustat in Healthy Subjects
    Dorien Groenendaal-van de Meent
    Martin den Adel
    Jan van Dijk
    Begona Barroso-Fernandez
    Rachid El Galta
    Georg Golor
    Marloes Schaddelee
    European Journal of Drug Metabolism and Pharmacokinetics, 2018, 43 : 685 - 692
  • [42] Safety, tolerability, and pharmacokinetics of raltegravir after single and multiple doses in healthy subjects
    Iwamoto, M.
    Wenning, L. A.
    Petry, A. S.
    Laethem, M.
    De Smet, M.
    Kost, J. T.
    Merschman, S. A.
    Strohmaier, K. M.
    Ramael, S.
    Lasseter, K. C.
    Stone, J. A.
    Gottesdiener, K. M.
    Wagner, J. A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 (02) : 293 - 299
  • [43] Pharmacokinetics, safety, and tolerability of oral posaconazole administered in single and multiple doses in healthy adults
    Courtney, R
    Pai, S
    Laughlin, M
    Lim, J
    Batra, V
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (09) : 2788 - 2795
  • [44] PHARMACOKINETICS, PHARMACODYNAMICS, SAFETY AND TOLERABILITY OF A NOVEL FACTOR XIA INHIBITOR ADMINISTERED AS IV INFUSION IN NON-JAPANESE AND JAPANESE HEALTHY SUBJECTS.
    Perera, V.
    Frost, C. E.
    Yones, C. L.
    Wang, Z.
    Dorizio, S.
    Russo, C.
    Chen, W.
    Ueno, T.
    Akimoto, M.
    Cirincione, B.
    Xu, X.
    Seiffert, D. A.
    Desouza, M. M.
    Mugnier, P.
    LaCreta, F.
    Frost, R. J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S42 - S42
  • [45] Safety, tolerability and pharmacokinetics of multiple oral doses of AFN-1252 administered as immediate release (IR) tablets in healthy subjects
    Hunt, Thomas
    Kaplan, Nachum
    Hafkin, Barry
    JOURNAL OF CHEMOTHERAPY, 2016, 28 (03) : 164 - 171
  • [46] SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF REPEAT DOSES OF THE NAV1.7-SELECTIVE SODIUM CHANNEL BLOCKER BIIB074 IN HEALTHY SUBJECTS.
    Naik, H.
    Steiner, D.
    Versavel, M.
    Palmer, J.
    Fong, R.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 : S56 - S56
  • [47] SAFETY, TOLERABILITY AND PHARMACOKINETICS OF SINGLE DOSES OF THE NAV1.7-SELECTIVE SODIUM CHANNEL BLOCKER BIIB074 IN HEALTHY SUBJECTS.
    Naik, H.
    Steiner, D.
    Versavel, M.
    Palmer, J.
    Fong, R.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 : S56 - S57
  • [48] THE EFFECTS OF MULTIPLE DOSES OF ROLOFYLLINE ON THE PHARMACODYNAMICS AND PHARMACOKINETICS OF WARFARIN AT STEADY STATE IN HEALTHY SUBJECTS.
    Dishy, V.
    Stroh, M.
    Hwang, E.
    Lazarus-Shipitofsky, N.
    Dittrich, H. C.
    Lai, E.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 : S11 - S11
  • [49] Comparison of pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel loading doses in healthy chinese and caucasian subjects.
    Small, D. S.
    Payne, C. D.
    Kothare, P. A.
    Yuen, E. S.
    Natanegara, F.
    Loh, M. T.
    Jakubowski, J. A.
    Winters, K. J.
    Farid, N. A.
    Ni, L.
    Li, Y. G.
    Salazar, D. E.
    Kelly, R. P.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S56 - S56
  • [50] Pharmacokinetics of esomeprazole after oral and intravenous administration of single and repeated doses to healthy subjects.
    Hassan-Alin, M
    Rohss, K
    Andersson, T
    Nyman, L
    GASTROENTEROLOGY, 2000, 118 (04) : A16 - A16
12345